首页> 外国专利> A HE3/ERB-3/C-ERB-3/C-RBB-3/C-ERB3 human antibody; coded nucleic acid; recombinant expression vector; including chemical precursors or metamorphic chemicals of this vector; production method of this antibody; understanding the pharmaceutical composition of this vector Use it to treat diseases.

A HE3/ERB-3/C-ERB-3/C-RBB-3/C-ERB3 human antibody; coded nucleic acid; recombinant expression vector; including chemical precursors or metamorphic chemicals of this vector; production method of this antibody; understanding the pharmaceutical composition of this vector Use it to treat diseases.

机译：HE3 / ERB-3 / C-ERB-3 / C-RBB-3 / C-ERB3人抗体;编码核酸重组表达载体包括该载体的化学前体或变质化学物质;该抗体的生产方法;了解此载体的药物成分可将其用于治疗疾病。

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to antibodies binding to human HER3 (anti-HER3 antibody), methods for their production, pharmaceutical compositions containing said antibodies, and uses thereof.

机译：本发明涉及与人HER3结合的抗体（抗HER3抗体），其制备方法，含有所述抗体的药物组合物及其用途。

著录项

公开/公告号CL2012001649A1

专利类型
公开/公告日2012-10-12

原文格式PDF
申请/专利权人 ROCHE GLYCART AG;
展开▼

申请/专利号CL20120001649
发明设计人 DIMOUDIS NIKOLAOS;BOSSENMAIER BIRGIT;FRIESS THOMAS;GEORGES GUY;KOLM IRENE;KRELL HANS WILLI;LIFKE VALERIA;MOESSNE;
展开▼

申请日2012-06-18
分类号A61K39/395;A61P35/00;C07H21/00;C07K16/28;C07K16/32;C12N15/63;C12N5/10;C12P21/02;
国家 CL
入库时间 2022-08-21 17:25:18

相似文献

专利
外文文献